Characterization of virus-specific cytotoxic T cell clones from allogeneic bone marrow chimeras
✍ Scribed by Hanspeter Pircher; Jürg Baenziger; Marco Schilham; Toshi Sado; Hitoko Kamisaku; Hans Hengartner; Rolf M. Zinkernagel
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 672 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We investigated the adoptive transfer of immunity to herpes simplex virus (HSV) in 61 recipients of T-cell-depleted marrow allografts. Up to 3 months after bone marrow transplantation (BMT), high titres of HSV antibody (Ab) are passively acquired from blood products. This antibody has a half-life of
Recipients of allogeneic bone marrow transplantation are pancytopenic for several weeks and immunosuppressed for many months as a result of myeloablative therapy required to eliminate the basic disease and to prevent allograft rejection. After bone marrow transplantation, these patients remain profo
## Abstract Previous work by Grob et al. [__Lancet__ i:774, 1987] has demonstrated that allogeneic, T‐cell‐depleted bone marrow transplant recipients have a better prognosis for reactivated cytomegalovirus (CMV) infection if their donor is also immune. It was proposed that adoptively transferred hu
A recent study reported that quantitation of cytomegalovirus (CMV)-specific CD8þ T lymphocytes in the graft and monitoring of these T cells might identify hematopoietic stem cell transplantation-recipients at the risk for progressive CMV infection. A 6-year-old girl underwent bone marrow transplanta